Pfizer to Acquire Stake in Brazilian Generics Firm

Pfizer says it will acquire a 40% stake in Laboratorio Teuto Brasileiro (Anápolis, Brazil), a leading generics company, and that the companies have entered into a partnership to develop and commercialize generic medicines. Pfizer will make an upfront payment of R$400 million ($240 million) and Teuto will be eligible to receive a performance-based milestone payment, under the terms of the deal. Pfizer has an option to acquire the remaining 60% of Teuto’s shares beginning 2014. The deal will enhance Pfizer’s position in Brazil, a key emerging...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers